These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 23379250)

  • 1. [Drug therapy in patients with adenoma of the prostate gland with urination disorders].
    Spivak LG; Vinarov AZ; Evdokimov MS
    Urologiia; 2012; (6):96-9. PubMed ID: 23379250
    [No Abstract]   [Full Text] [Related]  

  • 2. Editorial comment.
    de la Rosette JJ
    Urology; 2010 Jun; 75(6):1458. PubMed ID: 20513508
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of benign prostatic hyperplasia by phenol injection.
    Angell JC
    Br J Urol; 1969 Dec; 41(6):735-8. PubMed ID: 4188054
    [No Abstract]   [Full Text] [Related]  

  • 4. [Conservative therapy of prostatic hyperplasia with urinary retention].
    Djulepa J
    Med Welt; 1983 Dec; 34(48):1377-9. PubMed ID: 6197601
    [No Abstract]   [Full Text] [Related]  

  • 5. [Efficacy of prostatic adenoma treatment with alfusozine depending on sexuality].
    Kogan MI; Kireev AIu
    Urologiia; 2011; (1):28-31. PubMed ID: 21500491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug treatment for LUTS and BPH: new is not always better.
    Roehrborn CG
    Eur Urol; 2006 Jan; 49(1):5-7. PubMed ID: 16314029
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effects of therapy with progesterone in micturition disturbances due to prostatic hypertrophy].
    Cucinotta D; Passeri M
    Minerva Med; 1972 Apr; 63(27):1583-600. PubMed ID: 4112960
    [No Abstract]   [Full Text] [Related]  

  • 8. [Conservative therapy of prostate adenoma with phenoxybenzamine. Clinical aspects and urodynamics].
    Flamm J
    Fortschr Med; 1981 Nov; 99(43):1820-2. PubMed ID: 6171493
    [No Abstract]   [Full Text] [Related]  

  • 9. [Urination disorders caused by prostatic hyperplasia. Effect of Bazoton, Harzol and Prosta-capsules].
    Hallwachs O
    MMW Munch Med Wochenschr; 1981 Oct; 123(44):1675-6. PubMed ID: 6171728
    [No Abstract]   [Full Text] [Related]  

  • 10. Does the use of silodosin to treat benign prostatic hyperplasia really offer something new?
    Morgia G
    Eur Urol; 2011 Mar; 59(3):353-5; discussion 355. PubMed ID: 21130562
    [No Abstract]   [Full Text] [Related]  

  • 11. [Epidemiology of lower urinary tract symptoms and use of doxazosin in the treatment of early stages of benign prostate hyperplasia].
    Nurullaev RB
    Lik Sprava; 2004; (3-4):101-3. PubMed ID: 15318840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Medical treatment of fibroadenomatous hypertrophy of the prostate with a new plant substance].
    Maver A
    Minerva Med; 1972 May; 63(37):2126-36. PubMed ID: 4113157
    [No Abstract]   [Full Text] [Related]  

  • 13. By the way, doctor. I'm 77 and have an enlarged prostate. I take Proscar once a day and saw palmetto three times a day. Yet I still have to get up two to seven times a night to urinate. What can I do to reduce the frequency of urination?
    O'Leary MP
    Harv Health Lett; 2003 Apr; 28(6):8. PubMed ID: 12777237
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of hypertrophy of the prostate with gestagens].
    Vahlensieck W; Gödde S
    Munch Med Wochenschr; 1968 Jun; 110(26):1573-7. PubMed ID: 4182927
    [No Abstract]   [Full Text] [Related]  

  • 15. Editorial comment.
    Kaplan SA
    Urology; 2010 Jun; 75(6):1458-9. PubMed ID: 20513509
    [No Abstract]   [Full Text] [Related]  

  • 16. [Gestonorone therapy of prostatic adenoma].
    Lopatkin N; Darenkow A; Sahmatow J; Tankó A; Ignaschin N; Warentsow G
    Acta Chir Acad Sci Hung; 1980; 21(4):271-8. PubMed ID: 6175122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The objective of medical treatment: relieve the symptoms or stop the course?].
    Desgrandchamps F
    Ann Urol (Paris); 2006 Mar; 40 Spec No 1():14-6. PubMed ID: 16649585
    [No Abstract]   [Full Text] [Related]  

  • 18. [The evaluation of efficacy and safety of treatment with dalfaz SR in patients with prostatic adenoma].
    Rasner PI; Pushkar' DIu
    Urologiia; 2013; (3):34-6, 38. PubMed ID: 23987046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The place of pharmacologic treatment in benign prostatic hyperplasia.
    Caine M
    Semin Urol; 1985 Nov; 3(4):311-6. PubMed ID: 2441447
    [No Abstract]   [Full Text] [Related]  

  • 20. [Using setegis (terasosine) in early postoperative period after transurethral prostate resection].
    Teodorovich OV; Zabrodina NB; Bochkarev AB
    Urologiia; 2009; (3):62-4. PubMed ID: 19673124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.